Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2)

被引:1
|
作者
Youil, R
Kiselava, I
Kwan, WS
Szymkowiak, C
Toner, TJ
Su, Q
Klimov, A
Rudenko, L
Shaw, AR
机构
[1] Merck & Co Inc, Dept Virus & Cell Biol, W Point, PA 19486 USA
[2] Russian Acad Med Sci, Inst Expt Med, St Petersburg 197376, Russia
[3] Ctr Dis Control & Prevent, Influenza Branch, Atlanta, GA 30333 USA
关键词
cold-adaptive influenza vaccine; influenza A virus; vero cells;
D O I
10.1016/j.virusres.2004.01.026
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
For the past three decades the cold-adapted (ca) and temperature sensitive (ts) master donor strain, A/Leningrad/134/17/57 (H2N2) has been successfully used as the basis for the live attenuated reassortant influenza A vaccine. This donor strain was developed from A/Leningrad/134/57 (H2N2) wild-type (wt) virus following 17 passages in eggs at 25 degreesC. Our detailed investigation has revealed that the A/Leningrad/134/17/57 (Len/17) master donor stock is a mixed population comprised of numerous variants of the ca/ts Len/17 influenza virus. We have identified these variants to exhibit a broad range in their temperature sensitive phenotype when assayed on Madin-Darby canine kidney (MDCK) cells at 37 degreesC. A selection of these variant clones has been fully characterized by sequencing in order to understand the variability in the ts phenotype. This study has also addressed the feasibility of using cell culture technology for the propagation and subsequent manufacturing of the cold-adapted influenza vaccine (CAIV), particularly with respect to retaining the defined mutations that contribute toward the ca/ts phenotype. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 41 条
  • [21] Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 — Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines
    E. V. Krutikova
    E. A. Stepanova
    P. F. Wong
    I. V. Kiseleva
    E. P. Grigor’eva
    L. G. Rudenko
    Bulletin of Experimental Biology and Medicine, 2020, 168 : 669 - 672
  • [22] Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model
    J. Theo M. Voeten
    Irina V. Kiseleva
    Harrie L. Glansbeek
    Stephanie M. C. Basten
    Sandra K. M. Drieszen-van der Cruijsen
    Larisa G. Rudenko
    Han van den Bosch
    Jacco G. M. Heldens
    Archives of Virology, 2010, 155 : 1391 - 1399
  • [23] Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model
    Voeten, J. Theo M.
    Kiseleva, Irina V.
    Glansbeek, Harrie L.
    Basten, Stephanie M. C.
    Drieszen-van der Cruijsen, Sandra K. M.
    Rudenko, Larisa G.
    van den Bosch, Han
    Heldens, Jacco G. M.
    ARCHIVES OF VIROLOGY, 2010, 155 (09) : 1391 - 1399
  • [24] IDENTIFICATION OF SEQUENCE CHANGES IN THE COLD-ADAPTED, LIVE ATTENUATED INFLUENZA VACCINE STRAIN, A/ANN-ARBOR/6/60 (H2N2)
    COX, NJ
    KITAME, F
    KENDAL, AP
    MAASSAB, HF
    NAEVE, C
    VIROLOGY, 1988, 167 (02) : 554 - 567
  • [25] Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55-Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines
    Krutikova, E., V
    Stepanova, E. A.
    Wong, P. F.
    Kiseleva, I., V
    Grigor'eva, E. P.
    Rudenko, L. G.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 168 (05) : 669 - 672
  • [26] Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates
    Broadbent, Andrew J.
    Santos, Celia P.
    Paskel, Myeisha
    Matsuoka, Yumiko
    Lu, Janine
    Chen, Zhongying
    Jin, Hong
    Subbarao, Kanta
    VACCINE, 2015, 33 (01) : 193 - 200
  • [27] Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets
    Chen, Grace L.
    Lamirande, Elaine W.
    Jin, Hong
    Kemble, George
    Subbarao, Kanta
    VIROLOGY, 2010, 398 (01) : 109 - 114
  • [28] IMMUNOGENICITY FOR MICE OF ATTENUATED REASSORTANTS OF A/LENINGRAD/134/47/57 (H2N2) INFLUENZA-VIRUS WITH DIFFERENT GENOME COMPOSITION
    YEGOROV, AY
    GARMASHOVA, LM
    NEVEDOMSKAYA, GN
    BOGOMOLOVA, LI
    KHAIDER, AM
    ALEXANDROVA, GI
    VOPROSY VIRUSOLOGII, 1994, 39 (05) : 198 - 201
  • [29] SAFETY AND HIGH IMMUNOGENIC POTENCY FOR CHILDREN OF 3-15 YEARS OF MONOVACCINES AND BIVACCINES FROM INFLUENZA A/BRASIL/11/78 (H1N1) AND A/BANGKOK/1/79 (H3N2) VIRUS RECOMBINANTS OBTAINED ON THE BASIS OF A SPECIAL DONOR OF ATTENUATION, A COLD-ADAPTED A/LENINGRAD/134/47/57 (H2N2) VIRUSBR
    POLEZHAEV, FI
    BUDILOVSKY, GN
    GARMASHOVA, LM
    ROMEIKOGURKO, YR
    EGOROV, AY
    TOPURIYA, NV
    KOVAL, TA
    ALEKSANDROVA, GI
    VOPROSY VIRUSOLOGII, 1983, (06) : 710 - 714
  • [30] COMPARATIVE STUDIES OF WILD-TYPE AND COLD-MUTANT (TEMPERATURE-SENSITIVE) INFLUENZA-VIRUSES - POLYPEPTIDE SYNTHESIS BY AN ASIAN (H2N2) STRAIN AND ITS COLD-ADAPTED VARIANT
    KENDAL, AP
    KILEY, MP
    MAASSAB, HF
    JOURNAL OF VIROLOGY, 1973, 12 (06) : 1503 - 1511